Disclosure Policy
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Mariana Castells, MD

Consultant: Sanofi, Contrafect, Bentham Sciences, Insys

Advisory Board Member: Merck

Luz Fonacier, MD

Contracted Research: Genentech

Speaker Honorarium: Regeneron

Matt Greenhawt, MD

Consultant: Aimmune, Intromune, Thermo Fisher Scientific

Advisory Board Member: Kaléo, Nestle Nutrition Institute, Monsanto

Speaker: Thermo Fisher Scientific

The following have no financial relationships to disclose:

Sadia Hayat, MD

Nikita Raje, MD

Mamta Reddy, MD, MBOE

Nguyen Tran, MD

James Verbsky, MD

Kristen Welborn, RN, MSN, FNP-C